Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
First Look: Lululemon shake-up, Broadcom AI jitters, Costco beat
07:38am, Friday, 12'th Dec 2025
Stock News Lululemon leadership change lifts shares: Lululemon Athletica (LULU) said CEO Calvin McDonald will step down Jan. 31, with CFO Meghan Frank and CCO A
Breakfast News: Broadcom Guides Lower
07:30am, Friday, 12'th Dec 2025
Broadcom feels the heat of AI expectations, LULU soars over 10% on strong results, and more
Think Eli Lilly Is Expensive? This Metric Says Otherwise.
06:42am, Friday, 12'th Dec 2025
Eli Lilly's shares may appear expensive at first glance, but a closer look reveals a different story. The company's outlook is strong, and the stock is a buy, even at current levels.
Market Today: Fed Cut, Oracle Slide, Broadcom AI Surge
05:35pm, Thursday, 11'th Dec 2025
Stock News Oracle sinks, ripples across AI trade: Oracle (ORCL) fell about 11% after a revenue miss and heavier AI capex drove negative free cash flow, pressuri
Thursday's Final Takeaways: LLY Positive Drug Trial, Home Prices Turn Negative
05:26pm, Thursday, 11'th Dec 2025
Marley Kayden and Sam Vadas discuss Eli Lilly's (LLY) positive weight loss drug trial and how home prices turned negative. They also note that jobless claims rose and the trade deficit narrowed.
Dow Jones Today: Dow Sets All-Time High But Nasdaq, S&P 500 Fall as Oracle Results Drag AI Shares
12:00pm, Thursday, 11'th Dec 2025
Major stock indexes were mixed Thursday, with the Dow Jones Industrial Average setting a new all-time high but the Nasdaq and S&P 500 falling as Oracle results dragged AI-tied shares.
Eli Lilly's Latest Obesity Drug Delivers Strong Results. It Might Work Too Well.
11:23am, Thursday, 11'th Dec 2025
The company said some patients had dropped out of the trial because they felt they were losing too much weight.
2 Pharma Stocks Pop on Strong Obesity Drug Trial Results
11:16am, Thursday, 11'th Dec 2025
Positive drug trial results are boosting pharmaceutical stocks today, with Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) and Eli Lilly & Co. (NYSE:LLY) drawing investor attention after encouragin
Prison Fellowship Awarded $5 Million Grant From Lilly Endowment Inc. To Broaden Its Reach in Sharing Stories of Radical Restoration
11:15am, Thursday, 11'th Dec 2025
WASHINGTON, D.C., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Prison Fellowship, the nation's largest Christian nonprofit serving currently and formerly incarcerated people and their families and a leading advo
New Lilly Shot Reduces Body Weight by 23% in Study
10:59am, Thursday, 11'th Dec 2025
A next-generation obesity shot from Eli Lilly helped patients lose nearly a quarter of their body weight, potentially making the experimental drug the most potent weight-loss medicine yet. Madison Mul
Eli Lilly reports positive Phase 3 trial results for obesity drug retatrutide
10:21am, Thursday, 11'th Dec 2025
Eli Lilly and Co (NYSE:LLY) has reported positive topline results from its Phase 3 TRIUMPH-4 trial evaluating its obesity treatment retatrutide in adults with obesity and knee osteoarthritis. The inve
GOOGL Price Target Raise, SNPS Strong Guidance, LLY Retratrutide Results
10:15am, Thursday, 11'th Dec 2025
Oracle (ORCL) weighed on markets Thursday morning but Diane King Hall turns to stocks seeing strength. Synopsys (SNPS) added muscle to the tech trade with an earnings beat and strong 2026 guidance tha
Live Nasdaq Composite: Markets Retreat on AI Trade Fatigue
10:03am, Thursday, 11'th Dec 2025
Live Updates AI Bubbles 12 minutes ago Live Deutsche Bank says AI is in not one but two bubbles and both are still in the early stages. One is driven by cash-rich Big Tech companies pouring profits in
Oracle, AI Stocks Put a Dent in Sentiment
09:15am, Thursday, 11'th Dec 2025
Oracle (ORCL) is plummeting premarket, dragging the rest of the AI sector and weighing on the broader market
Eli Lilly's newest weight-loss drug relieved pain in patients with knee osteoarthritis
07:55am, Thursday, 11'th Dec 2025
Eli Lilly's “triple g” drug helped patients lose about 28.7% of their body weight while also reducing pain associated with knee osteoarthritis in a Phase 3 trial.
